Trials / Unknown
UnknownNCT04317209
A Study of SHR0410 in Hemodialysis Patients With Pruritus
A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study on Safety, Tolerability and Pharmacokinetics of SHR0410 in Hemodialysis Subjects With Moderate to Severe Pruritus
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the safety, tolerability and pharmacokinetics of SHR0410 in hemodialysis patients with moderate to severe pruritus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0410 | administered intravenously |
| DRUG | Placebo | administered intravenously |
Timeline
- Start date
- 2020-05-17
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2020-03-23
- Last updated
- 2020-05-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04317209. Inclusion in this directory is not an endorsement.